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INTRODUCTION
Copper is essential micronutrient and is 
required for the formation of many enzymes, 
with important role in the human body. It has 
an important role in pregnancy for the forma­
tion of a wide variety of enzymatic and other 
processes within the developing foetus. During 
pregnancy, many changes occur in copper levels 
and transport in both mother and foetus. The 
serum copper increases in early pregnancy and 
continues to rise to reaching levels at full term 
approximately twice those found in non­preg­
nant women. Maternal age does not influence 
copper serum levels [1].
Some analyses have shown substantially 
lower plasma concentrations of copper in path­
ological conditions diagnosed during the first 
trimester of pregnancy (spontaneous abor­
tion, threatened abortion, missed abortion 
and blighted ovum). No significant differences 
in maternal plasma blood copper concentra­
tions have been found in pathological condi­
tions (threatened abortion, threatened preterm 
delivery and pyelonephritis) diagnosed in the 
second trimester of pregnancy. Tendencies to 
higher plasma copper concentrations, however 
statistically insignificant, can be observed in 
other pathological conditions during the third 
trimester (gestosis, intrauterine growth retar­
dation, preterm labour) [2].
Copper is delivered to the developing foetus 
via specific transporters in the placenta that are 
regulated by the mother’s estrogen and insulin 
levels. These findings have implications for bet­
ter understanding of preeclampsia, intrauterine 
growth retardation, the development of babies 
born to mothers with gestational diabetes and 
some genetic disorders [3].
OBjECTIvE
Aims of this study were: 1) to estimate levels 
of serum copper values in healthy non­preg­
nant women, healthy pregnant women and 
to find out if there is a change in serum cop­
per levels during normal pregnancy, delivery 
and the postpartum period, and if so, to deter­
mine the level of significance compared with 
the serum copper values in healthy non­preg­
nant women; 2) to determine if there is a sig­
nificant difference between the mean serum 
copper levels in different weeks of gestational 
age of healthy pregnant women with normal 
course of pregnancy; 3) to find out if there is a 
change of serum copper levels in some patho­
logical pregnancies (habitual abortion, immi­
nent abortion, abortion in progress, missed 
abortion, missed labour and premature rup­
ture of membranes) and if so, at which sig­
nificant level compared with serum copper 
values in healthy pregnant women with nor­
mal pregnancy course and in healthy non­
pregnant women; 4) to determine if there is a 
significant difference in serum copper values 
SUMMARy
Introduction Copper is essential micronutrient and has an important role in the human body. The serum 
copper increases during pregnancy and is doubled at full term. Lower levels of serum copper in preg­
nancy are connected with some pathological conditions.
Objective The aim of this study was to estimate the levels of serum copper in normal and pathological 
pregnancies, comparing them with values of serum copper in non­pregnant women, to determine if 
serum copper is lower in some pathological pregnancies and if this is of some importance.
Methods A total of 2170 plasma samples for copper analyses were made in the following groups: healthy 
non­pregnant women; healthy pregnant women from the 5th­40th gestational week, during the first 
delivery stage and during the first three postpartum weeks, in pregnant women with habitual abortion, 
imminent abortion, abortion in progress, missed abortion (9th­24th weeks), missed labour and prema­
ture rupture of membranes (29th­40th weeks). Levels of serum copper were determined by colorimetric 
technique of bathocuproin with disulphate as a chromogen.
Results Serum copper values in non­pregnant women range from 11.6­25.8 µmol/L. In healthy preg­
nant women, there is a constant trend of the increase of serum copper. The mean serum copper val­
ues revealed three significant peaks at the 22nd, 27th and 35th gestational week. Serum copper values in 
the patients with some pathological pregnancies in relation to the serum copper values of the healthy 
pregnant women were significantly lower.
Conclusion Serum copper values can be used as an indicator of some pathological pregnancies.
keywords: serum copper; pregnancy; missed labour; spontaneous abortion; premature rupture of 
membranes43
www.srp­arh.rs
Srp Arh Celok Lek. 2012;140(1­2):42­46
between the investigated pathological pregnancies; and 
5) after having acquired all previous results, to estimate 
the influence of serum copper levels on the outcome of 
pregnancy and its significance for the prediction and con­
trol of some pathological pregnancies.
METHODS
A total of 2170 maternal plasma samples for copper 
analyses were made in the following groups of women:
Control group – a: Healthy non­pregnant women (N=31) 
of fertile age with no therapy administered for at least 6 
months before investigation and during the investigation.
Control group – b: A total of 1240 serum copper deter­
minations were performed in healthy pregnant women with 
normal course of pregnancy with no hormonal therapy 
applied, with no diseases (pregnancy related or not related 
to pregnancy) of either genital or some other organs. The 
patients were distributed into groups of 31 women in each 
gestational week from the 5th­40th gestational week; in the 
first delivery stage (term delivery with intact membranes 
and the average cervical dilation of 4­5cm N=31), and in 
the 1st, 2nd and 3rd week postpartum (delivery completed 
at term and no obstetric intervention applied, 7, 14 and 21 
days after delivery; 31 women in each week). Women were 
not followed longitudinally.
Groups with pathological pregnancies: Serum cop­
per was analyzed in every week from the 9th­24th weeks of 
pregnancy in women with habitual abortion (more than 3 
spontaneous abortions, normal clinical findings, whereas 
the reason for hospitalization was a “burdened” obstet­
ric history, N= 165) ; imminent abortion (small amount 
of bleeding from the uterus, slight lower abdominal pain, 
cervix closed, N=177); abortion in progress (cervix com­
pletely opened, embryo and trophoblast protruding from 
the cervix, with blood taken immediately after the com­
pleted spontaneous abortion, N=178); missed abortion 
(non­viable embryo/foetus, N=190). Serum copper was 
estimated in every week from the 29th­40th weeks of ges­
tational age in women with missed labour (vaginal deliv­
ery, stillborn foetus over 1000 g of weight, with no sings 
of either maceration or foetal malformations, blood taken 
before the delivery, N=31) and women with premature rup­
ture of membranes (blood samples obtained 24­48 h after 
membrane rupture in vital pregnancy, N=158). Women 
with abortion in progress, missed abortion and missed 
labour were, at some point in the study, formed as a group 
of „pathological pregnancies with bad outcome”.
In all investigated patients gestational age was deter­
mined by ultrasound. Blood samples were obtained from 
the cubital vein in the morning, on an empty stomach.
The copper content of blood serum was determined by 
colorimetric technique of bathocuproin with disulphate 
as a chromogen.
Data were analyzed with descriptive statistical meth­
ods and the t­test by SPPS program (testing significance of 
correlation coefficient, SD for ungrouped data, percentage 
structure of arithmetical median values, standard errors, 
t­test for two unrelated groups with different number of 
cases and others.).
RESULTS
In healthy non­pregnant women, serum copper values 
ranged from 11.6­25.8 µmol/L (mean value 20.15 µmol/L).
In healthy pregnant women with normal course of preg­
nancy, there was a constant trend of the increase of the 
mean serum copper values comparing to the mean serum 
copper values in healthy non­pregnant women. The results 
of t­test (t=4.66) suggested a high statistical significance 
(p<0.01) in the period between the 7th gestational week 
and 4th postpartum week. Analyzes showed three signifi­
cant peaks (p<0.01) of the serum copper levels at the 22nd, 
27th and 35th weeks of pregnancy, while maximal values 
were recorded in the interval between the 38th and 40th 
weeks of pregnancy.
There was a decrease of the mean serum copper values 
of 9% during the first stage of delivery comparing to the 
mean serum copper values in healthy pregnant women 
during the 40th week of pregnancy (p<0.05).
During the first postpartum week, the decrease of mean 
serum copper values of 15.8% was recorded in relation to 
the mean serum copper values of the pregnant women 
during the first delivery stage (p<0.01). On the basis of 
the trend of decrease of the mean serum copper values 
after delivery, it could be concluded with a high probabil­
ity (95.45%) that during the 5th postpartum week, the mean 
serum copper values would decrease to the level of those 
obtained in healthy non­pregnant women.
The mean values obtained in the serum of healthy preg­
nant women with a normal course of pregnancy repre­
sented the standard course. Dispersion of individual serum 
copper values within a range of ±2 SD can represent the 
standard of the general trend of serum copper values in 
normal pregnancy.
In pathological pregnancies (habitual abortion, immi­
nent abortion, missed abortion, missed labour, spon­
taneous abortion, premature rupture of membranes) 
the mean serum copper values were significantly lower 
(p<0.01) comparing with the mean values obtained in the 
serum of healthy pregnant women with a normal course 
of pregnancy. There was no statistical significant differ­
ence (p>0.05) in the trend of mean serum copper values 
between analyzed pathological pregnancies.
Therefore, the trends of serum copper values in the 
patients with the above mentioned pathological conditions 
during the 1st­40th gestational week could be presented by 
common tabular values (Table 1), i.e. the common graph 
Table 1. Variations of serum copper values through trimesters of preg­
nancy in normal and pathological pregnancies
Pregnancy
Serum copper value (μmol/l)
I 
trimester
II 
trimester
III 
trimester
Normal 24­43 30­52 35­60
Pathological 17­25 22­30 27­35
Pathological with bad outcome <17 <22 <2744
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(Graph 1). For better overview in the table (Table 1), preg­
nancy was divided in three trimesters, and pathological 
pregnancies with bad outcome (abortion in progress, 
missed abortion and missed labour) are shown separately, 
because of lower serum copper levels in these conditions 
(although not statistically significant).
DISCUSSION
Copper (Cu) is an oligoelement which is a constitutional 
part of each cell. Its biological value could be compared 
with hormones, vitamins and ferments. Atomic weight 
of copper is 63.57, specific weight 8.93­8.95, and atomic 
number 29. About 96% of plasma copper is firmly bound 
to ceruloplasmin.
In physiological and pathological conditions, the 
increase of serum copper values is varying in dependence 
on the increase of serum ceruloplasmin and its surplus is 
excreted through urine. Copper plays the main biochemical 
role being a component of metalloenzymes and metallo­
proteinase. A common characteristic of enzymes contain­
ing copper is their ability of using elementary oxygen as 
a substrate for oxidation and hydroxylation. Most met­
alloenzymes are oxidases, hydroxilases and superoxide 
dismutases. Physiological functions related to copper are 
based on the biochemical functions of one or more cop­
per metalloenzymes. Serum copper levels are influenced 
by numerous humoral factors [2, 4­10].
In pregnancy, copper levels in maternal serum rise, more 
or less in parallel with increases in serum ceruloplasmin. 
At the same time, total body copper levels increase, but 
not in the tissues normally associated with copper home­
ostasis. The placental transport system changes during the 
latter stages of the development resulting in the transport 
of higher copper values towards the end of gestation than 
that of earlier pregnancy. Most of the copper transferred 
across the placenta is found in the foetal liver, and dur­
ing pregnancy serum levels in the foetus actually drop. 
Copper uptake is a carrier­mediated process, while intra­
cellular transfer is mediated by proteins known as chap­
erones. The copper uptake is enhanced by a high affinity 
carrier Ctr1, which is expressed early in pregnancy, trans­
ferred to chaperones and carried to the ATPases, where it 
is pumped across the cell membrane. Copper is delivered 
to the developing foetus via specific transporters in the 
placenta that are regulated by the mother’s estrogen and 
insulin levels [11].
 These findings have implications for better understand­
ing of preeclampsia, intrauterine growth retardation, the 
development of babies born to mothers with gestational 
diabetes and some genetic disorders. Lipid peroxides in 
serum and placental tissue, and iron, copper and ceru­
loplasmin levels in serum were significantly increased in 
pregnant women with severe eclampsia [3].
During pregnancy, the metabolism of copper and iron 
is tightly interlinked and the deficiency of one has marked 
effects on the metabolism of the other metal. In the mother, 
iron deficiency results in the increase of liver copper levels. 
This is associated with an increase of serum copper levels 
in the mother and in the activity of maternal serum ceru­
loplasmin. Given the high incidence of maternal anaemia 
during pregnancy, and that many of those who are pre­
scribed iron supplements show no significant improve­
ment, it is tempting to conclude that at least some of the 
cases are the consequence of low copper when consider­
ing iron supplement administration, copper status must 
be also taken into account [3].
Adequate maternal copper supply is essential for nor­
mal embryogenesis. Studies in laboratory animals as well 
as in domestic animals under field conditions have shown 
that maternal copper deficiency produces effects ranging 
from intrauterine growth retardation and teratogenesis to 
embryonic or foetal death. Persistent postnatal complica­
Graph 1. Variations of serum copper values through trimesters of pregnancy in normal and risk­ patholgical pregnancies45
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tions of prenatal copper deficiency can also occur. Current 
data suggest that changes in free radical defence mecha­
nisms, connective tissue metabolism and energy produc­
tion can all contribute to the dysmorphogenesis associated 
with developmental copper deficiency.
Increased number of complications in pregnancy 
requires a simple, cheap and practical test which could 
quickly determine the functional condition of the placenta 
and foetus. Some authors [2, 9­16] suggest that serum cop­
per levels can be used as a very sensitive indicator of condi­
tion and further possible course of pregnancy and placental 
functions.
Out of the total of all risk pregnancies (20­30% of all 
pregnancies), 10­20% are spontaneous abortions, though 
some authors claim the percentage is even higher (31%).
Almost ¾ of spontaneous abortions occur between the 
11th and 12th gestational week. Imminent abortion (abortus 
imminens) is most frequent (about 40%) of all clinically 
manifested forms. About 4% of all spontaneous abortions 
belong to habitual abortion (abortus habitualis). Habitual 
abortions are most complicated regarding cause, treatment 
and prognosis. The risk of repeated spontaneous abortions 
with the next pregnancy is 22%, and after three sponta­
neous abortions, it rises up to 47%. The causes of spon­
taneous abortion and stillbirth are numerous and yet not 
completely explained (missed abortion, missed labour). 
Aetiology of premature rupture of membranes is a com­
plex issue. The literature data [2, 10, 12] suggest that serum 
copper decrease leads to a reduction of elastin and collagen 
resulting in premature rupture of membranes.
Through the scope of literature [1­19] data, we have 
come to a conclusion that prior to this study, there were 
no relevant standard values of normal copper serum lev­
els established concerning normal pregnancy, delivery and 
postpartum period as well as some pathological pregnan­
cies. On the basis of the results achieved in this study, we 
suggest that the lower levels of serum copper in pregnancy 
could be predictors of some pathological pregnancies 
(habitual abortion, imminent abortion, missed abortion, 
missed labour, spontaneous abortion, premature rupture 
of membranes) and should be introduced into the proto­
col of routine prenatal diagnostics.
CONCLUSION
This study reveals serum copper values in healthy non­
pregnant women which range from 11.6­25.8 μmol/L. A 
constant trend of increase of mean serum copper values 
during normal pregnancy is detected compared to mean 
serum copper values in healthy non­pregnant women. 
The mean serum copper values in investigated patients 
with some pathological pregnancies: habitual abortion, 
imminent abortion, abortion in progress, missed abor­
tion, missed labour and premature membrane rupture were 
found to be statistically significantly lower than in the nor­
mal course of pregnancy. On the basis of these results, a 
graph of normal values for serum copper in pregnancy 
is established together with values for some pathological 
pregnancies. We conclude that these serum copper values 
can be used as an indicator of the condition of pregnancy 
and foetoplacental unit, and could be introduced into the 
protocol of routine prenatal diagnostics as a simple, cheap 
and accurate method.
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КРАТАК САДРжАЈ
Увод  Ба кар  је  есен ци јал ни  оли го е ле мент  и  има  ва жну  уло­
гу у људ ском те лу. Вред ност ба кра у се ру му се по ве ћа ва то­
ком труд но ће и у тер ми ну је дво стру ко ве ћа. Ни же вред но­
сти  по ве за не  су  с  не ким  па то ло шким  ста њи ма  у  труд но ћи.
Циљ ра да Циљ ра да био је да се од ре де про ме не ни воа ба­
кра  у  се ру му  то ком  нор мал не  и  па то ло шке  труд но ће,  а  за­
тим ове вред но сти упо ре де с ку пре ми јом не гра вид них же­
на и утвр  ди да ли је у не  ким па  то  ло  шким труд  но  ћа  ма ни  во 
ба  кра био ни  жи, од  но  сно има ли ово не  ког зна  ча  ја.
Ме то де  ра да  Ура ђе но  је  2.170  ана ли за  вред но сти  ба кра  у 
се ру му: код здра вих не гра вид них же на, здра вих гра вид них 
же на по не де ља ма ге ста ци је (од 5. до 40. не де ље), то ком пр­
вог  по ро ђај ног  до ба  и  пр ве  три  пост пар тал не  не де ље,  код 
же на са че стим по ба ча ји ма, пре те ћим по ба ча јем, по ба ча јем 
у  то ку,  из о ста лим  (тзв.  mis sed) по  ба  ча  јем (од 9. до 24. не  де­
ље труд но ће), код ин тра у те ру сне смр ти пло да и пре вре ме­
ног  пр сну ћа  во де ња ка  (од  29.  до  40.  не де ље  труд но ће).  Ни­
вои  ба кра  су  од ре ђи ва ни  ко ло ри ме триј ском  тех ни ком  ба­
то ку про и на  са  ди сул фа том  као  хро мо ге ном.
Ре зул та ти Вред но сти ба кра у се ру му не гра вид них же на би­
ле су 11,6–25,8 µmol/l. Код здра вих труд ни ца уоче но је стал­
но  по ве ћа ње  ку пре ми је  то ком  труд но ће,  са  три  вр хун ца  – 
у  22,  27.  и  35.  не де љи  ге ста ци је;  нај ви ше  вред но сти  би ле  су 
из  ме  ђу 38. и 40. не  де  ље. Ни  вои ба  кра у се  ру  му же  на са па­
то ло шком  труд но ћом  би ли  су  зна чај но  ни жи.
За кљу чак Вред но сти ба кра у се ру му мо гу се ко ри сти ти као 
ин ди ка тор  не ких  па то ло шких  труд но ћа.
Кључ не ре чи: ба кар у се ру му; труд но ћа; спон та ни по ба чај; 
ин тра у те ру сна  смрт;  пре вре ме но  пр сну ће  во де ња ка
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